Merck KGaA (MKKGY) News Today $28.42 +0.83 (+3.01%) As of 10/3/2025 03:57 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartDividendEarningsHeadlinesShort InterestBuy This Stock MKKGY Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Merck KGaA (OTCMKTS:MKKGY) Sees Large Decrease in Short InterestOctober 5 at 4:38 PM | marketbeat.comHow Does Merck KGaA's (XTRA:MRK) Genome Editing Push Reshape Its Innovative Edge?October 3 at 11:44 AM | finance.yahoo.comMerck KGaA (OTCMKTS:MKKGY) Shares Down 2.7% - Here's WhyOctober 2 at 12:49 AM | marketbeat.comHalf of Merck’s sales are in jeopardy. Can Keytruda’s sequel save the day?October 2 at 3:40 PM | finance.yahoo.comWhy Merck (MRK) Stock Is Up TodayOctober 1, 2025 | msn.comMerck (MRK) Jumps 6.8% on Trump Tariffs, Stellar Pulmonary Hypertension Drug TrialOctober 1, 2025 | msn.comMerck KGaA (OTCMKTS:MKKGY) Shares Gap Up - Still a Buy?October 1, 2025 | marketbeat.comMerck’s (MRK) Oncology Portfolio Gets Shot in the Arm with QLEX NodSeptember 26, 2025 | msn.comMerck KGaA stock falls after naming Kai Beckmann as new CEOSeptember 25, 2025 | za.investing.comMerck and Siemens extend digital transformation partnership in life sciencesSeptember 23, 2025 | msn.comChinese police investigating app fraud case, says German drugmaker Merck KGaASeptember 23, 2025 | reuters.comJim Cramer on Merck: “I Think You Continue to Hold It”September 22, 2025 | msn.comMerck Snags A Key Approval Before Its Cash Cow Goes Off A Patent CliffSeptember 22, 2025 | msn.comFDA Approves Merck's Cancer Drug Keytruda InjectionSeptember 19, 2025 | marketwatch.comUS FDA approves Merck's injectable version of blockbuster cancer therapy KeytrudaSeptember 19, 2025 | msn.comMerck Gets Positive Opinions From Europe's CHMP on Keytruda, EnflonsiaSeptember 19, 2025 | marketwatch.comMerck to create 200 jobs as €150m filtration manufacturing facility opens in BlarneySeptember 18, 2025 | msn.comUK ‘difficult’ operating environment says Merck boss after £1bn London site axedSeptember 17, 2025 | msn.comAstraZeneca follows Merck’s pullback in Britain: reportSeptember 12, 2025 | msn.comAstra, Lilly are latest to reevaluate U.K. investments after Merck’s pullback: reportsSeptember 12, 2025 | msn.comBlow for UK drugs sector as Merck scraps £1bn expansionSeptember 11, 2025 | bbc.comBMerck scraps £1bn London expansion as report warns UK drugs sector ‘losing out’September 11, 2025 | msn.comMerck Reportedly Scraps Research Centre In UK: Retail Sees Stock Rallying To $97.50September 10, 2025 | msn.comMerck Scraps £1 Billion London Hub in Fresh Blow to UKSeptember 10, 2025 | msn.comBiocytogen Enters into Agreement with Merck, KGaA, Darmstadt, Germany to Advance Antibody-Conjugated Lipid-Based Delivery SolutionsSeptember 3, 2025 | businesswire.comMerck (MRK) Announces Positive Results From Phase 3 CORALreef Lipids TrialSeptember 2, 2025 | finance.yahoo.comMerck KGaA, Darmstadt, Germany, Appoints David Weinreich as New Global Head of R&D and Chief Medical Officer for Healthcare Business SectorSeptember 2, 2025 | finanznachrichten.deMerck Provides New Results for VERQUVO® (vericiguat) in Patients with Chronic Heart Failure and Reduced Ejection FractionAugust 30, 2025 | finance.yahoo.comMerck (MRK) Unveils New Cardiovascular Research Data at ESC 2025 CongressAugust 25, 2025 | finance.yahoo.comMerck KGaA (OTCMKTS:MKKGY) Stock Rating Lowered by BarclaysAugust 22, 2025 | marketbeat.comMerck shares snapped six-session winning streakAugust 20, 2025 | msn.comMerck KGaA (OTCMKTS:MKKGY) Shares Gap Down - Time to Sell?August 20, 2025 | marketbeat.comMerck KGaA Signs $2 Billion Neurology Drug Pact With SkyhawkAugust 18, 2025 | bloomberg.comTata, Merck explore exclusive chemical deal for Dholera semiconductor facilityAugust 15, 2025 | msn.comMerck KGaA (OTCMKTS:MKKGY) Posts Quarterly Earnings ResultsAugust 10, 2025 | marketbeat.comMerck KGaA (OTCMKTS:MKKGY) Sees Strong Trading Volume After Strong EarningsAugust 10, 2025 | marketbeat.comIs Wall Street Bullish or Bearish on Merck Stock?August 4, 2025 | finance.yahoo.comN.J.-based Merck announces $3B in cost cutting measures including layoffsJuly 31, 2025 | msn.comMerck KGaA (MKKGY) Expected to Announce Quarterly Earnings on ThursdayJuly 31, 2025 | marketbeat.comJefferies Raises Merck (MRK) Price Target, Maintains Buy RatingJuly 18, 2025 | msn.comBristol Myers fails in late-stage trial for Merck-partnered anemia therapy in blood cancerJuly 18, 2025 | msn.comVerona Pharma (VRNA) Jumps 125% YTD; Merck $10-Billion Acquisition Bolsters SentimentJuly 17, 2025 | msn.comEurope is lagging behind in AI-specific patents: Merck KGaAJuly 16, 2025 | msn.comMerck KGaA (OTCMKTS:MKKGY) Shares Gap Down - Should You Sell?July 14, 2025 | marketbeat.comMerck KGaA (OTCMKTS:MKKGY) Shares Up 0.2% - Here's What HappenedJuly 10, 2025 | marketbeat.comPharma Giant Merck Buys Lung Therapy Firm Verona For $10 BillionJuly 9, 2025 | baystreet.caVerona Pharma shares jump with Merck set to acquire company in $10 billion dealJuly 9, 2025 | msn.comKennedy's US Vaccine Panel Votes in Favor of Merck's RSV Antibody DrugJune 26, 2025 | usnews.comMerck KGaA (OTCMKTS:MKKGY) Sees Significant Drop in Short InterestJune 18, 2025 | marketbeat.comBenchling and Merck collaborate on vaccine bioanalysisJune 15, 2025 | msn.com Get Merck KGaA News Delivered to You Automatically Sign up to receive the latest news and ratings for MKKGY and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MKKGY Media Mentions By Week MKKGY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MKKGY News Sentiment▼0.650.54▲Average Medical News Sentiment MKKGY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MKKGY Articles This Week▼84▲MKKGY Articles Average Week Get the Latest News and Ratings for MKKGY and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Merck KGaA and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Zoetis News Today Daiichi Sankyo News Today Takeda Pharmaceutical News Today BeOne Medicines News Today Sandoz Group News Today United Therapeutics News Today Summit Therapeutics News Today Shionogi & Co., Ltd. Unsponsored ADR News Today Neurocrine Biosciences News Today IPSEN News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:MKKGY) was last updated on 10/5/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredU.S. Government Sparking Crypto RallyU.S. Puts GDP on the Blockchain Could this spark the next crypto supercycle? Discover the altcoins poised t...Crypto 101 Media | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredMelt-up warning Porter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in hi...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Merck KGaA Please log in to your account or sign up in order to add this asset to your watchlist. Share Merck KGaA With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MKKGY Stock Alerts